Inclusion Criteria:  Undergoing uncomplicated cataract surgery with or without a posterior chamber intraocular lens (IOL) implantation. If a contact lens is used for correction of post-operative aphakia, it must be a silicone elastomer lens or a rigid gas permeable lens (no water content). Other protocol-specified inclusion criteria may apply.  Exclusion Criteria:  Presence of clinically significant gastrointestinal, cardiovascular, hepatic, renal, hematological, endocrine, neurological, psychiatric, respiratory, or other medical condition that could increase the risk to the subject as determined by the investigator. Has a post-traumatic cataract. Presence of active or suspected viral, bacterial, or fungal disease in the study eye. Ocular hypertension with an IOP in the study eye >25 mmHg at Screening with or without treatment with anti-glaucoma monotherapy. Subjects who have received a periocular corticosteroid injection in the study eye in the 3 months prior to Screening. Subjects who have received any intravitreal corticosteroid delivery vehicle (eg, Retisert®, Ozurdex®, Iluvien®) in the study eye at any time. Other protocol-specified exclusion criteria may apply